Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candida antigen immunotherapy in cutaneous warts
NCT04399577Phase 2Completed
- Sponsor
- Zagazig University
- Start
- Jul 2017
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of candida albicans antigen in cutaneous warts, sponsored by Zagazig University. Started Jul 2017; status: completed.
02
Drugs
candida albicans antigen
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT04399577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04399577.